These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9654337)

  • 1. Effects of neurotoxic doses of methamphetamine on potassium and amphetamine evoked overflow of dopamine in the striatum of awake rats.
    Cass WA; Manning MW; Dugan MT
    Neurosci Lett; 1998 Jun; 248(3):175-8. PubMed ID: 9654337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restorative effects of GDNF on striatal dopamine release in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Manning MW; Bailey SL
    Ann N Y Acad Sci; 2000 Sep; 914():127-36. PubMed ID: 11085315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Manning MW
    J Neurosci; 1999 Sep; 19(17):7653-60. PubMed ID: 10460271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation and recovery of evoked overflow of striatal serotonin in rats treated with neurotoxic doses of methamphetamine.
    Cass WA
    J Neurochem; 2000 Mar; 74(3):1079-85. PubMed ID: 10693939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine.
    Cass WA
    J Pharmacol Exp Ther; 1997 Jan; 280(1):105-13. PubMed ID: 8996187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term effects of neurotoxic doses of methamphetamine on the extracellular concentration of dopamine measured with microdialysis in striatum.
    Robinson TE; Yew J; Paulson PE; Camp DM
    Neurosci Lett; 1990 Mar; 110(1-2):193-8. PubMed ID: 1691471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat.
    Cass WA; Harned ME; Peters LE; Nath A; Maragos WF
    Brain Res; 2003 Sep; 984(1-2):133-42. PubMed ID: 12932847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats.
    Gerhardt GA; Maloney RE
    Brain Res; 1999 Jan; 816(1):68-77. PubMed ID: 9878690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine.
    Baldwin HA; Colado MI; Murray TK; De Souza RJ; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):590-6. PubMed ID: 8467354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration.
    Cass WA; Walker DJ; Manning MW
    Brain Res; 1999 May; 827(1-2):104-12. PubMed ID: 10320698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitriol protects against reductions in striatal serotonin in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Peters LE
    Neurochem Int; 2023 Oct; 169():105590. PubMed ID: 37536650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo microdialysis studies of age-related alterations in potassium-evoked overflow of dopamine in the dorsal striatum of Fischer 344 rats.
    Stanford JA; Giardina K; Gerhardt GA
    Int J Dev Neurosci; 2000; 18(4-5):411-6. PubMed ID: 10817924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the neurotoxic effects of methamphetamine by the selective kappa-opioid receptor agonist U69593.
    El Daly E; Chefer V; Sandill S; Shippenberg TS
    J Neurochem; 2000 Apr; 74(4):1553-62. PubMed ID: 10737612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to the neurotoxic effect of methamphetamine in rats behaviorally sensitized to methamphetamine or amphetamine.
    Abekawa T; Ohmori T; Koyama T
    Brain Res; 1997 Aug; 767(1):34-44. PubMed ID: 9365013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
    Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ
    Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitriol promotes augmented dopamine release in the lesioned striatum of 6-hydroxydopamine treated rats.
    Cass WA; Peters LE; Fletcher AM; Yurek DM
    Neurochem Res; 2014 Aug; 39(8):1467-76. PubMed ID: 24858239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic stress augments the long-term and acute effects of methamphetamine.
    Matuszewich L; Yamamoto BK
    Neuroscience; 2004; 124(3):637-46. PubMed ID: 14980734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo assessment of striatal dopamine release in the aged male Fischer 344 rat.
    Kametani H; Iijima S; Spangler EL; Ingram DK; Joseph JA
    Neurobiol Aging; 1995; 16(4):639-46. PubMed ID: 8544915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine.
    Cass WA
    J Neurosci; 1996 Dec; 16(24):8132-9. PubMed ID: 8987838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice.
    Kita T; Matsunari Y; Saraya T; Shimada K; O'Hara K; Kubo K; Wagner GC; Nakashima T
    Int J Dev Neurosci; 2000 Oct; 18(6):521-30. PubMed ID: 10884597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.